Developer docs
API playgroundTry for free, no card

Search company profiles

Intalight

Full company profile

uuid002y9l8

Namestring
Intalight
Legal namestring
Intalight Inc.
Websiteurl
intalight.com
Company typeenum
Private
Founded yearint
2014
Descriptiontext

Intalight is a medical device company that develops and commercializes Swept-Source Optical Coherence Tomography (SS-OCT) systems for ophthalmic imaging. Founded in 2014 in Silicon Valley by a group of scientists and industry veterans, the company moved its operational base to mainland China in 2015 and now maintains three sites in San Jose, Shanghai, and Luoyang. Its flagship product, DREAM OCT, launched in 2019 as the world's first 200kHz commercial SS-OCT system, integrates five imaging modalities — Retinal OCT, Retinal OCTA, Anterior Segment OCT, Anterior Segment OCTA, and biometry — into a single device with imaging depths of 12mm (retina) and 16.2mm (anterior segment) and ultra-widefield coverage up to 200° via montage.

The platform incorporates proprietary algorithms including TrueAngio for OCTA flow detection, Deep Layer AI for retinal layer segmentation, and 3D Projection Artefact Removal (PAR), supported by over 170 peer-reviewed publications and collaborations with more than 500 global institutions. The business model is anchored in capital equipment sales of the high-end DREAM OCT system to retina specialists, comprehensive ophthalmologists, glaucoma specialists, and cornea/refractive surgeons, supplemented by regional support and service contracts across APAC, EMEA, and the Americas. Distribution combines a direct field sales organization with channel partners (Adapt in Brazil), and the company has obtained regulatory clearance in China (NMPA, 2019), Brazil (ANVISA, June 2024), and the European Union (CE Mark, May 2025), with a US FDA 510(k) submission in process.

Short descriptiontext

Intalight is a medical device company that develops and sells the DREAM OCT Swept-Source Optical Coherence Tomography system — a high-end 5-in-1 ophthalmic imaging platform — to retina specialists, comprehensive ophthalmologists, and academic research institutions globally.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSan Jose, United States
HQ citystring
San Jose
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
swept-source OCT, ophthalmic imaging devices, optical coherence tomography, retinal imaging systems, medical diagnostic imaging
Industry3 codes
1Retinal Imaging & OCT Systems (OCT/OCTA, Fundus Cameras, Fluorescein/ICG Angiography)
CodeHLAHAJABPrimaryYes
2Cornea, External Disease & Refractive Surgery (LASIK/PRK)
CodeHLAKAKAFPrimaryNo
3Vision & Ophthalmic Diagnostic Centers (Optometry/OCT/Retinal Imaging)
CodeHLAFAKAIPrimaryNo
NAICS code3 codes
  • Ophthalmic Goods Manufacturing339115
  • Surgical and Medical Instrument Manufacturing339112
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code3 codes
  • Optical Instruments & Lenses3827
  • Surgical & Medical Instruments & Apparatus3841
  • Ophthalmic Goods3851
Product category
Ophthalmic Diagnostic Imaging
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Medical Device Hardware Sales
TypeHardware Sales
Description

Intalight generates revenue through the sale of DREAM OCT medical imaging devices, a high-end ophthalmic diagnostic system priced at premium tier for ophthalmologists and eye care institutions. The company also plans to extend product portfolios from ophthalmic diagnostic devices to operational instruments.

intalight.com
2Support and Service Contracts
TypeProfessional Services
Description

Regional support and service operations provide ongoing maintenance, software updates, and technical assistance to customers in APAC, EMEA, and Americas regions through dedicated service email contacts.

intalight.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1DREAM OCT™
Description

Swept-Source Optical Coherence Tomography (OCT) device combining Deep imaging depth, Rapid sweeping speed, Extensive scan range, Accurate lesion detection and Multimodal imaging capabilities. Also known as如意全眼OCT in Chinese markets.

intalight.com
Core offering1 text field

Intalight designs, manufactures, and commercializes the DREAM OCT™ platform, a Swept-Source Optical Coherence Tomography (SS-OCT) medical imaging device for ophthalmology. The system integrates Retinal OCT, Retinal OCTA, Anterior Segment OCT (AS-OCT), AS-OCTA, and visualized biometry in a single device, enabling ophthalmologists to perform comprehensive retinal and anterior segment diagnostics. The company sells the hardware along with associated service contracts, and is extending its portfolio from diagnostic devices toward operational surgical instruments.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Over 170 peer-reviewed papers published in scientific journals based on DREAM OCT findings
+3 more records
Product overview1 text field

Intalight develops advanced ophthalmic technologies focused on Optical Coherence Tomography (OCT) imaging. The core product is DREAM OCT™ (branded as 如意全眼OCT in China), a Swept-Source OCT system that integrates multiple imaging modalities (Retinal OCT, Retinal OCTA, AS-OCT, AS-OCTA, and biometry) into a single device. The company is expanding from ophthalmic diagnostic devices to operational instruments. The product portfolio targets retina specialists, comprehensive ophthalmologists, and research institutions globally.

Product and service2 records
1DREAM OCT™ (VG-200/VG-200D)
CategoryOphthalmic Diagnostic Imaging Hardware
Description

Swept-Source Optical Coherence Tomography medical imaging device for ophthalmologists and eye care institutions, integrating Retinal OCT, Retinal OCTA, AS-OCT, AS-OCTA and visualized biometry in a single system. Provides 12mm retina and 16.2mm anterior segment imaging depth, scan speeds up to 400KHz, and 130° single-scan OCTA coverage extending to 200° with montage.

2如意全眼OCT (Chinese market brand for DREAM OCT)
CategoryOphthalmic Diagnostic Imaging Hardware
Description

Chinese market branding of the DREAM OCT Swept-Source OCT platform, integrating axial length biometry, anterior segment OCT, posterior segment OCT, anterior segment OCTA, and posterior segment OCTA in a single device for ophthalmologists in China.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2024-06-01
Description

Adapt serves as Intalight's distribution partner in Brazil following ANVISA regulatory approval. Adapt is described as one of the largest ophthalmology companies in the country, offering products for surgical and diagnostic areas including cataracts, glaucoma, retinal, dry eye, and refractive errors. Joe Garibaldi stated confidence in Adapt's ability to represent Intalight as experts in OCT technology.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global ophthalmic device leader whose CIRRUS spectral-domain and PLEX Elite swept-source OCT systems directly compete with DREAM OCT across retina and anterior segment. Comparable premium-tier pricing and customer base of comprehensive ophthalmologists and retina specialists.

TypeBroad incumbent
Description

Diversified ophthalmic device maker offering the Maestro2 (multi-modal OCT/fundus) and 3D OCT-1 series. Competes with DREAM OCT across comprehensive ophthalmology and integrated diagnostic workflows in retina and glaucoma practices.

TypeBroad incumbent
Description

Japan-based ophthalmic equipment manufacturer whose Mirante and RS-330 swept-source OCT products compete with DREAM OCT. Comparable target customers in retina, glaucoma, and refractive surgery with global distribution.

TypeDirect peer
Description

Now part of Visionix/Briot, Optovue pioneered OCT Angiography (AngioVue) and is one of Intalight's primary competitive targets. Notably, Intalight's CCO Joe Garibaldi was previously VP Global Commercialization at Optovue, giving direct competitive insight.

TypeDirect peer
Description

Specialist OCT and confocal imaging company (Spectralis, Spectralis OCTA) targeting the same retina specialist and academic ophthalmology customers as Intalight. Both companies compete on widefield, swept-source OCT performance and clinical-evidence depth.

TypeEmerging player
Description

Specializes in swept-source laser technology for OCT (OptiPolis laser source) and ophthalmic imaging. Relevant as a competing SS-OCT technology supplier with comparable focus on ultra-widefield and high-speed scanning.

TypeEmerging player
Description

Handheld and table-top retinal imaging company expanding into OCT. Targets similar primary-care and screening ophthalmology use cases but at lower price points than DREAM OCT, with comparable AI-driven imaging analysis.

TypeEmerging player
Description

Revenio-owned diagnostic imaging and tonometry device maker. Comparable as a premium ophthalmic diagnostic hardware vendor pursuing integrated clinic platforms across glaucoma, retina, and screening workflows.

TypeEmerging player
Description

China-based ophthalmic imaging company offering OCT products to APAC and emerging markets. Most comparable as a Chinese-origin, internationally expanding OCT competitor to Intalight's value-tier devices.

TypeBroad incumbent
Description

Canon's ophthalmic division (built on Optopol's OCT heritage) markets the Xephilio OCT-A1 swept-source OCT directly competing on imaging depth and widefield OCTA — overlapping capabilities with DREAM OCT's core differentiators.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Intalight

Ophthalmic Diagnostic Imagingintalight.com

Intalight is a medical device company that develops and sells the DREAM OCT Swept-Source Optical Coherence Tomography system — a high-end 5-in-1 ophthalmic imaging platform — to retina specialists, comprehensive ophthalmologists, and academic research institutions globally.

What Intalight does

Intalight is a medical device company that develops and commercializes Swept-Source Optical Coherence Tomography (SS-OCT) systems for ophthalmic imaging. Founded in 2014 in Silicon Valley by a group of scientists and industry veterans, the company moved its operational base to mainland China in 2015 and now maintains three sites in San Jose, Shanghai, and Luoyang. Its flagship product, DREAM OCT, launched in 2019 as the world's first 200kHz commercial SS-OCT system, integrates five imaging modalities — Retinal OCT, Retinal OCTA, Anterior Segment OCT, Anterior Segment OCTA, and biometry — into a single device with imaging depths of 12mm (retina) and 16.2mm (anterior segment) and ultra-widefield coverage up to 200° via montage.

The platform incorporates proprietary algorithms including TrueAngio for OCTA flow detection, Deep Layer AI for retinal layer segmentation, and 3D Projection Artefact Removal (PAR), supported by over 170 peer-reviewed publications and collaborations with more than 500 global institutions. The business model is anchored in capital equipment sales of the high-end DREAM OCT system to retina specialists, comprehensive ophthalmologists, glaucoma specialists, and cornea/refractive surgeons, supplemented by regional support and service contracts across APAC, EMEA, and the Americas. Distribution combines a direct field sales organization with channel partners (Adapt in Brazil), and the company has obtained regulatory clearance in China (NMPA, 2019), Brazil (ANVISA, June 2024), and the European Union (CE Mark, May 2025), with a US FDA 510(k) submission in process.

Intalight firmographics

Firmographics
Name
Intalight
Legal name
Intalight Inc.
Website
https://intalight.com
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
11–50 employees
Short description
Intalight is a medical device company that develops and sells the DREAM OCT Swept-Source Optical Coherence Tomography system — a high-end 5-in-1 ophthalmic imaging platform — to retina specialists, comprehensive ophthalmologists, and academic research institutions globally.
Ownership category
akta.pro rank

Intalight industry classification

Industry
Product category
Ophthalmic Diagnostic Imaging
NAICS
Ophthalmic Goods Manufacturing (339115), Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Optical Instruments & Lenses (3827), Surgical & Medical Instruments & Apparatus (3841), Ophthalmic Goods (3851)
akta.pro primary industry
Retinal Imaging & OCT Systems (OCT/OCTA, Fundus Cameras, Fluorescein/ICG Angiography) (HLAHAJAB)
akta.pro secondary industries
Cornea, External Disease & Refractive Surgery (LASIK/PRK) (HLAKAKAF), Vision & Ophthalmic Diagnostic Centers (Optometry/OCT/Retinal Imaging) (HLAFAKAI)

Keywords

  • Swept-source OCT
  • Ophthalmic imaging devices
  • Optical coherence tomography
  • Retinal imaging systems
  • Medical diagnostic imaging

Where Intalight is headquartered

Location

Headquarters

HQ city
San Jose
HQ country
United States
HQ region
North America

Offices3 records

Markets served

Intalight business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations

Revenue model

  1. Medical Device Hardware Sales: Intalight generates revenue through the sale of DREAM OCT medical imaging devices, a high-end ophthalmic diagnostic system priced at premium tier for ophthalmologists and eye care institutions. The company also plans to extend product portfolios from ophthalmic diagnostic devices to operational instruments.
  2. Support and Service Contracts: Regional support and service operations provide ongoing maintenance, software updates, and technical assistance to customers in APAC, EMEA, and Americas regions through dedicated service email contacts.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Intalight product offering

Product offering

Core offering

Intalight designs, manufactures, and commercializes the DREAM OCT™ platform, a Swept-Source Optical Coherence Tomography (SS-OCT) medical imaging device for ophthalmology. The system integrates Retinal OCT, Retinal OCTA, Anterior Segment OCT (AS-OCT), AS-OCTA, and visualized biometry in a single device, enabling ophthalmologists to perform comprehensive retinal and anterior segment diagnostics. The company sells the hardware along with associated service contracts, and is extending its portfolio from diagnostic devices toward operational surgical instruments.

Product overview

Intalight develops advanced ophthalmic technologies focused on Optical Coherence Tomography (OCT) imaging. The core product is DREAM OCT™ (branded as 如意全眼OCT in China), a Swept-Source OCT system that integrates multiple imaging modalities (Retinal OCT, Retinal OCTA, AS-OCT, AS-OCTA, and biometry) into a single device. The company is expanding from ophthalmic diagnostic devices to operational instruments. The product portfolio targets retina specialists, comprehensive ophthalmologists, and research institutions globally.

Differentiator

Problem solved

Functional benefit

Brands

  • DREAM OCT™: Swept-Source Optical Coherence Tomography (OCT) device combining Deep imaging depth, Rapid sweeping speed, Extensive scan range, Accurate lesion detection and Multimodal imaging capabilities. Also known as如意全眼OCT in Chinese markets.

Products and services

  • DREAM OCT™ (VG-200/VG-200D) Swept-Source Optical Coherence Tomography medical imaging device for ophthalmologists and eye care institutions, integrating Retinal OCT, Retinal OCTA, AS-OCT, AS-OCTA and visualized biometry in a single system. Provides 12mm retina and 16.2mm anterior segment imaging depth, scan speeds up to 400KHz, and 130° single-scan OCTA coverage extending to 200° with montage.
  • 如意全眼OCT (Chinese market brand for DREAM OCT) Chinese market branding of the DREAM OCT Swept-Source OCT platform, integrating axial length biometry, anterior segment OCT, posterior segment OCT, anterior segment OCTA, and posterior segment OCTA in a single device for ophthalmologists in China.

Quantifiable outcome

  • Over 170 peer-reviewed papers published in scientific journals based on DREAM OCT findings
  • +3 more outcomes

Companies that use Intalight

Customer profile

Named customers2 records

Segments4 records

Ideal customer profiles2 records

Intalight technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature6 records

Intalight partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • AdaptcoreChannel Partner/ Reseller/ Distributor · 1 June 2024Adapt serves as Intalight's distribution partner in Brazil following ANVISA regulatory approval. Adapt is described as one of the largest ophthalmology companies in the country, offering products for surgical and diagnostic areas including cataracts, glaucoma, retinal, dry eye, and refractive errors. Joe Garibaldi stated confidence in Adapt's ability to represent Intalight as experts in OCT technology.

Scale indicators4 records

Recent moves7 records

Expansion highlights5 records

Intalight competitors and assessment

Company assessment

Broad incumbents

  • Carl Zeiss Meditec: Global ophthalmic device leader whose CIRRUS spectral-domain and PLEX Elite swept-source OCT systems directly compete with DREAM OCT across retina and anterior segment. Comparable premium-tier pricing and customer base of comprehensive ophthalmologists and retina specialists.
  • Topcon Healthcare: Diversified ophthalmic device maker offering the Maestro2 (multi-modal OCT/fundus) and 3D OCT-1 series. Competes with DREAM OCT across comprehensive ophthalmology and integrated diagnostic workflows in retina and glaucoma practices.
  • Nidek: Japan-based ophthalmic equipment manufacturer whose Mirante and RS-330 swept-source OCT products compete with DREAM OCT. Comparable target customers in retina, glaucoma, and refractive surgery with global distribution.
  • Canon (Optopol Technology): Canon's ophthalmic division (built on Optopol's OCT heritage) markets the Xephilio OCT-A1 swept-source OCT directly competing on imaging depth and widefield OCTA — overlapping capabilities with DREAM OCT's core differentiators.

Direct peers

  • Optovue (Visionix): Now part of Visionix/Briot, Optovue pioneered OCT Angiography (AngioVue) and is one of Intalight's primary competitive targets. Notably, Intalight's CCO Joe Garibaldi was previously VP Global Commercialization at Optovue, giving direct competitive insight.
  • Heidelberg Engineering: Specialist OCT and confocal imaging company (Spectralis, Spectralis OCTA) targeting the same retina specialist and academic ophthalmology customers as Intalight. Both companies compete on widefield, swept-source OCT performance and clinical-evidence depth.

Emerging players

  • Lumibird Medical: Specializes in swept-source laser technology for OCT (OptiPolis laser source) and ophthalmic imaging. Relevant as a competing SS-OCT technology supplier with comparable focus on ultra-widefield and high-speed scanning.
  • Optomed (Revenio Group): Handheld and table-top retinal imaging company expanding into OCT. Targets similar primary-care and screening ophthalmology use cases but at lower price points than DREAM OCT, with comparable AI-driven imaging analysis.
  • iCare (Revenio): Revenio-owned diagnostic imaging and tonometry device maker. Comparable as a premium ophthalmic diagnostic hardware vendor pursuing integrated clinic platforms across glaucoma, retina, and screening workflows.
  • Sonostar Technologies: China-based ophthalmic imaging company offering OCT products to APAC and emerging markets. Most comparable as a Chinese-origin, internationally expanding OCT competitor to Intalight's value-tier devices.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Intalight social profiles

Digital presence

Intalight compliance and trust

Trust signal

Compliance4 records

Intalight financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Intalight leadership team

Management profile

Number of profiles

Profiles3 records

Intalight funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Intalight M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Intalight

What does Intalight do?

Intalight designs, manufactures, and commercializes the DREAM OCT™ platform, a Swept-Source Optical Coherence Tomography (SS-OCT) medical imaging device for ophthalmology. The system integrates Retinal OCT, Retinal OCTA, Anterior Segment OCT (AS-OCT), AS-OCTA, and visualized biometry in a single device, enabling ophthalmologists to perform comprehensive retinal and anterior segment diagnostics. The company sells the hardware along with associated service contracts, and is extending its portfolio from diagnostic devices toward operational surgical instruments.

Is Intalight a public or private company?

Intalight is a private company. It is classified as venture growth investor backed and is currently operating.

When was Intalight founded?

Intalight was founded in 2014. It employs 11 to 50 people.

Where is Intalight based?

Intalight is headquartered in San Jose, United States, in the North America region.

How does Intalight make money?

Two revenue lines are on record. Medical Device Hardware Sales are the primary driver. The others are support and Service Contracts.

Who are Intalight's main competitors?

Broad incumbents on record are Carl Zeiss Meditec, Topcon Healthcare, Nidek and Canon (Optopol Technology). Direct peers are Optovue (Visionix) and Heidelberg Engineering. Emerging players are Lumibird Medical, Optomed (Revenio Group), iCare (Revenio) and Sonostar Technologies.

Does Intalight have an API?

No public API is recorded for Intalight.

What industry is Intalight in?

Intalight's product category is Ophthalmic Diagnostic Imaging. Its primary akta.pro industry code is HLAHAJAB, Retinal Imaging & OCT Systems (OCT/OCTA, Fundus Cameras, Fluorescein/ICG Angiography), with a secondary code of HLAKAKAF, Cornea, External Disease & Refractive Surgery (LASIK/PRK). Its NAICS code is 339115 and its SIC code is 3827.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales